News & Research
Find all the latest research, news and updates on Alzheimer’s disease blood-based biomarkers. Stay up to date with the latest educational materials from the BBM Workgroup.
Featured Stories
The Global CEO Initiative on Alzheimer’s Disease Publishes the First Performance Recommendations for Blood-Based Biomarker Tests by Experts in the Field
BBM Workgroup Activities & Educational Content:
Filter by Category: Research articles | News | Press Releases | Workgroup Activities | Education
Experts raise concerns about Quest Diagnostics’ consumer-initiated Alzheimer’s test
Experts have raised concerns about Quest Diagnostics’ $399 consumer-initiated Alzheimer’s disease test, telling 360Dx that it is unclear whether the product is accurate enough to support its use
Direct-to-Consumer Alzheimer’s Blood Test Opens Pandora’s Box
The first direct-to-consumer Alzheimer’s disease blood test has arrived. Quest Diagnostics, a worldwide diagnostic service headquartered in Secaucus, New Jersey, announced on July 31 that it would market a plasma Aβ42/ Aβ40 Alzheimer’s test to the public.